Treatment-Free Remission after TKIs Is Feasible Among Patients with CML in Low-Income Countries | Blood Cancers Today In a study of patients with CML in low- and middle-income countries who received TKIs, most patients remained relapse-free after a follow-up of 6 months or more.

Treatment-free life is now an option for eligible patients. A huge step forward!

Thanks to our local partners for collaborating on patient-centered care 🙏🏾

Read more about TFR for LMICs: buff.ly/cLes0Ub

#TreatmentFreeRemission #ChronicMyeloidLeukemia #HealthEquity #AccessToCare #TheMaxFoundation

Today, Leona is a proud grandmother, a dancer, and a volleyball player. 🏐 Her story reminds us that behind every diagnosis is a person with dreams.💙

buff.ly/GoK80oo

#TreatmentFreeRemission #ChronicMyeloidLeukemia #TheMaxFoundation #GlobalHealth #PatientStories

🔬 Because everyone deserves the chance to live beyond cancer.

👉🏽 Love what you see?
Comment “infographic” below and we’ll send you the content of this carousel as a downloadable PDF!

#WorldCMLDay #WorldCMLDay2025 #GlobalHealth #TheMaxFoundation #CancerCare #HealthForAll #TreatmentFreeRemission